AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Aug 16, 2013
29755_dirs_2013-08-16_0201ab06-fed4-4e30-b69e-78a49682cd85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-08-14
Reporting Person: HURWICH THOMAS A. (VP, Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-14 | Common stock, $0.01 par value | M | 1465 | $27.1537 | Acquired | 49883 | Direct |
| 2013-08-14 | Common stock, $0.01 par value | M | 3793 | $27.3719 | Acquired | 53676 | Direct |
| 2013-08-14 | Common stock, $0.01 par value | M | 703 | $27.9329 | Acquired | 54379 | Direct |
| 2013-08-14 | Common stock, $0.01 par value | M | 5351 | $27.6264 | Acquired | 59730 | Direct |
| 2013-08-14 | Common stock, $0.01 par value | M | 191 | $29.4031 | Acquired | 59921 | Direct |
| 2013-08-14 | Common stock, $0.01 par value | F | 9138 | $44.93 | Disposed | 50783 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-08-14 | Option (right to buy) | $27.1537 | M | 1465 | Disposed | 2014-02-19 | Common stock (1465) | Direct |
| 2013-08-14 | Option (right to buy) | $27.3719 | M | 3793 | Disposed | 2014-02-19 | Common stock (3793) | Direct |
| 2013-08-14 | Option (right to buy) | $27.9329 | M | 703 | Disposed | 2014-02-19 | Common stock (703) | Direct |
| 2013-08-14 | Option (right to buy) | $27.6264 | M | 4373 | Disposed | 2014-02-19 | Common stock (4373) | Direct |
| 2013-08-14 | Option (right to buy) | $27.6264 | M | 978 | Disposed | 2014-02-19 | Common stock (978) | Direct |
| 2013-08-14 | Option (right to buy) | $29.4031 | M | 191 | Disposed | 2014-02-19 | Common stock (191) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 1158 | Acquired | 2014-02-19 | Common stock (1158) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 3006 | Acquired | 2014-02-19 | Common stock (3006) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 562 | Acquired | 2014-02-19 | Common stock (562) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 3479 | Acquired | 2014-02-19 | Common stock (3479) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 778 | Acquired | 2014-02-19 | Common stock (778) | Direct |
| 2013-08-14 | Option (right to buy) | $44.93 | A | 155 | Acquired | 2014-02-19 | Common stock (155) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 393 | Indirect |
| Common stock, $0.01 par value | 274 | Indirect |
Footnotes
F1: Balance in AbbVie Savings Program as of August 14, 2013.
F2: The reporting person disclaims beneficial ownership of all securities held by his spouse.
F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4